Co-Administration of GSK Biologicals' Meningococcal Vaccine GSK134612 With Infanrix-Hexa, Compared to Individual Administration of Each Vaccine, in Healthy 12- Through 23-Month-Old Children.

Trial Profile

Co-Administration of GSK Biologicals' Meningococcal Vaccine GSK134612 With Infanrix-Hexa, Compared to Individual Administration of Each Vaccine, in Healthy 12- Through 23-Month-Old Children.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Oct 2016

At a glance

  • Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa); Meningococcal vaccine group C conjugate
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Meningococcal infections; Pertussis; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics; Registrational
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 17 Mar 2011 Results published in Vaccine.
    • 23 Oct 2008 Actual end date changed from May 2008 to Oct 2008 as reported by ClinicalTrials.gov.
    • 07 Sep 2008 Actual patient number (793) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top